Pharmacokinetics, Biodistribution, and Biosafety of PEGylated Gold Nanoparticles In Vivo

Pharmacokinetics, Biodistribution, and Biosafety of PEGylated Gold Nanoparticles In Vivo

Despite the obvious advantages of gold nanoparticles for biomedical applications, controversial and incomplete toxicological data hamper their widespread use. Here, we present the results from an in vivo toxicity study using gold nanoparticles coated with polyethylene glycol (PEG-AuNPs). The pharmac...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Katarina Kozics, Monika Sramkova, Kristina Kopecka, Patricia Begerova, Alena Manova, Zora Krivosikova, Zuzana Sevcikova, Aurelia Liskova, Eva Rollerova, Tibor Dubaj, Victor Puntes, Ladislava Wsolova, Peter Simon, Jana Tulinska, Alena Gabelova
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: MDPI AG 2021-06-01
Sarja:Nanomaterials
Aiheet:
gold nanoparticles
rats
pharmacokinetics
biodistribution
histopathology
clinical chemistry
Linkit:https://www.mdpi.com/2079-4991/11/7/1702

Internet

https://www.mdpi.com/2079-4991/11/7/1702

Samankaltaisia teoksia